News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
European Commissioner for Health and Food Safety 2019-2024 calls to join OncoThon
Stella Kyriakides/X
Feb 14, 2025, 15:36

European Commissioner for Health and Food Safety 2019-2024 calls to join OncoThon

Stella Kyriakides, European Commissioner for Health and Food Safety 2019-2024, posted on Facebook:

“Save the Date – Tomorrow we join our voices for Childhood cancer!”

Read Further: The Second Global OncoThon.

cancer Childhood Cancer OncoDaily Oncology Stella Kyriakides
Special Coverage
Blog
May 8, 2025, 18:13
Highlights from the NCCN Oncology Policy Summit 2025
Opinion
May 8, 2025, 18:12
Erman Akkus highlights new platinum derivatives Aurkine 16 and 18 for cancer treatment
Career
May 8, 2025, 18:06
Wafik S. El-Deiry congratulated Brooke Verschleiser on winning 2025 Llealyn B. Clapp Prize at the Brown University
Career
May 8, 2025, 18:00
E. John Wherry elected to National Academy of Sciences for cancer immunotherapy research
Opinion
May 8, 2025, 17:53
Rahul Banerjee on impact of CBER decision on cancer care
Career
May 8, 2025, 17:44
Thor Halfdanarson on 2025 Mayo Clinic Oncology Review course featuring ASCO highlights
Blog
May 8, 2025, 17:38
Kristiyana Kaneva: Does Starting a New Job Feel Like Going Through the Five Stages of Grief?
Celebrities
May 8, 2025, 17:36
Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football
Insight
May 8, 2025, 17:31
Stephen V Liu highlights SYS6010 ADC Data in EGFR-mutant NSCLC at AACR25
Blog
May 8, 2025, 17:30
Michelle Mitchell Reflects on CRUK Leadership Community Meeting
Insight
May 8, 2025, 17:23
Triparna Sen presented new research on immune evasion in Small Cell Lung Cancer at AAI IMMUNOLOGY 2025
Insight
May 8, 2025, 17:11
Praveen Kumar Marimuthu highlights EMBRACE II as a new standard of care for locally advanced cervical cancer